Early detection of cardiac fibrosis in diabetic mice by targeting myocardiopathy and matrix metalloproteinase 2
Acta Biomaterialia · 2024-03 · 176 · 367-378
DOI: 10.1016/j.actbio.2024.01.017 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2024-03. Verfasst von Hanrui Liu und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Obstet & Gynecol & Pediat Dis, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Experimental, Diabetic Cardiomyopathies, Ferric Compounds. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Sichuan Province Science and Technology Support Program, National Natural Science Foundation of China, Sichuan University.
Abstract (Originalsprache)
Early detection of myocardial fibrosis in diabetic cardiomyopathy (DCM) has significant clinical implications for diabetes management. In this study, we identified matrix metalloproteinase 2 (MMP2) as a potential biomarker for early fibrosis detection. Based on this finding, we designed a dual-targeting nanoparticle CHP-SPIO-ab MMP2 to specifically target myocardiopathy and MMP2, enabling sensitive fibrosis detection using magnetic resonance imaging (MRI). Our results demonstrate that collagen hyperplasia (early fiber formation) begins to develop in diabetic mice at 12 weeks old, with observable fibrosis occurring at 16 weeks old. Additionally, MMP2 expression significantly up-regulates around collagen starting from 12 weeks of age. T2 MRI analysis revealed significant T2% enhancement in the hearts of 12-week-old diabetic mice following administration of the CHP-SPIO-ab MMP2 probe, indicating noninvasive detection of fiber formation. Furthermore, after fibrosis treatment, a reduction in T2% signal was observed in the hearts of 16-week-old diabetic mice. These findings were supported by Sirius red and Prussian blue staining techniques. Overall, our study presents a promising strategy for early identification of myocardial fibrosis. STATEMENT OF SIGNIFICANCE: Myocardial damage typically exhibits irreversibility, underscoring the paramount importance of early fibrosis diagnosis. However, the clinical used T1 mapping for fibrosis detection still exhibits limitations in terms of sensitivity. Therefore, it is imperative to develop highly sensitive strategies for early cardiac fibrosis detection. Here, we investigated the development of myocardial fibrosis in diabetic mice, and designed a highly sensitive probe that specifically targets cardiomyopathy and high expression of MMP2 for the early diagnosis of fibrosis. The probe enables non-invasive detection of abnormalities through MRI imaging as soon as fiber deposition appear, which can be detected earlier than T1 mapping. This advancement holds great potential for clinical diagnosis of myocardial fibrosis using cardiac magnetic resonance.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Key Laboratory of Obstet & Gynecol & Pediat Dis, West China Second University Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
- Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
- Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
- National Engineering Research Center for Biomaterials, College of Biomedical Engineering, Sichuan University, Chengdu 610064, China.
- Department of Pediatrics and Key Laboratory of Birth Defects and Related Diseases of Women and Children of MOE, West China Second University Hospital, Sichuan University, China.
- Department of Radiology, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China. Electronic address: yangzg666@163.com.
Förderung
- Sichuan Province Science and Technology Support Program
- National Natural Science Foundation of China
- Sichuan University
- Fundamental Research Funds for the Central Universities
Zitieren
APA
Liu, H., Yan, W., Ma, C., Zhang, K., Li, K., Jin, R., Xu, H., Xu, R., Tong, J., Yang, Z., & Guo, Y. (2024). Early detection of cardiac fibrosis in diabetic mice by targeting myocardiopathy and matrix metalloproteinase 2. Acta Biomaterialia, 176, 367-378. https://doi.org/10.1016/j.actbio.2024.01.017
Vancouver
Liu H, Yan W, Ma C, Zhang K, Li K, Jin R, et al. Early detection of cardiac fibrosis in diabetic mice by targeting myocardiopathy and matrix metalloproteinase 2. Acta Biomaterialia. 2024;176:367-378. doi:10.1016/j.actbio.2024.01.017
BibTeX
@article{Liu2024,
author = {Liu, Hanrui and Yan, Weifeng and Ma, Chengyong and Zhang, Kun and Li, Kuan and Jin, Rongrong and Xu, Huayan and Xu, Rong and Tong, Jiyu and Yang, Zhigang and Guo, Yingkun},
title = {Early detection of cardiac fibrosis in diabetic mice by targeting myocardiopathy and matrix metalloproteinase 2},
journal = {Acta Biomaterialia},
year = {2024},
volume = {176},
pages = {367--378},
doi = {10.1016/j.actbio.2024.01.017}
}
EUVIMED